Logo Icon
OrthoLength Pro Clinical & Patient Community
Log in Register
MEDICAL DISCLAIMER: The information provided on OrthoLength Pro is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified orthopedic surgeon.
Fact Checked by Clinical Team Study Summary

Flexor Tendon Reconstruction Guide

Ka
Karagergou E, Baxevanou M, Moy...
April 08, 2026
1 views
View on PubMed
6 min read 1,003 words flexor tendon reconstruction Medically Reviewed

Overview

Flexor tendon reconstruction is a surgical procedure used to repair damaged flexor tendons in the hand. This procedure is often necessary for individuals who have suffered injuries that cannot be treated with primary repair, such as lacerations or ruptures. A recent study (Source: PubMed) compared the outcomes of two different techniques for single-stage flexor tendon reconstruction: tendon grafting and the turnover tendon split-lengthening technique.

What This Study Examined

The study examined the long-term functional outcomes and complication rates of these two techniques in patients with flexor tendon injuries. The researchers retrospectively reviewed the medical records of 14 patients who underwent single-stage flexor tendon reconstruction between 2014 and 2022. Seven patients received tendon grafts, and seven underwent the turnover split-lengthening procedure.

Why This Matters for Patients

This study is important for patients who have suffered flexor tendon injuries and are considering surgical reconstruction. The findings of this study can help patients understand the potential benefits and risks of each technique and make informed decisions about their treatment. Additionally, the study highlights the challenges of secondary tendon reconstruction and the need for careful patient selection and post-operative care.

Medical Background

Flexor tendon reconstruction is a complex surgical procedure that requires a thorough understanding of the anatomy and function of the flexor tendons. The flexor tendons are responsible for enabling finger bending and are essential for grasping and manipulating objects. When these tendons are damaged, it can result in significant disability and impairment.

How the Procedure Works

The procedure involves making an incision in the palm or finger to access the damaged tendon. The surgeon then uses either a tendon graft or the turnover split-lengthening technique to reconstruct the damaged tendon. The tendon graft is typically harvested from the palmaris longus tendon in the forearm.

Who Is a Candidate?

Candidates for flexor tendon reconstruction are individuals who have suffered flexor tendon injuries that cannot be treated with primary repair. This may include patients with lacerations, ruptures, or other types of tendon damage. Patients who have adequate soft tissue coverage and no excessive scarring are typically good candidates for the procedure.

Clinical Summary

  • Procedure: Flexor tendon reconstruction using either tendon grafting or turnover split-lengthening technique
  • Typical Duration: 1-2 hours
  • Recovery: 3-6 months
  • Success Rate (general): 70-80%

Study Methodology

The study used a retrospective design to review the medical records of 14 patients who underwent single-stage flexor tendon reconstruction. The patients were followed for a mean duration of 5.7 years, and the outcomes were assessed using the total active range of motion (AROM), grip strength, and the Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) score.

Patient Selection Criteria

The patients were selected based on their medical records, and the inclusion criteria included adequate soft tissue coverage and no excessive scarring. Patients who underwent two-stage reconstructions were excluded from the study.

Outcome Measures

The outcome measures used in the study included the total active range of motion (AROM), grip strength, and the QuickDASH score. The total active range of motion (AROM) was assessed using the modified Strickland formula.

Results & Findings

The study found that the mean total active range of motion (AROM) was 67.6%, and the mean grip strength was 90.7% of the contralateral hand. The mean QuickDASH score was 2.9. There were no statistically significant differences between the tendon grafting and turnover split-lengthening technique in terms of AROM, grip strength, or QuickDASH scores.

Key Outcomes

The study found that both techniques provided comparable functional outcomes, grip strength, and patient-reported satisfaction. However, a greater proportion of patients treated with tendon grafting achieved excellent or good outcomes according to the Strickland criteria.

Complications & Risks

The study found that complications were observed in 50% of patients, predominantly in those with suboptimal functional results. The complications included tendon adhesions, joint contractures, and bowstringing. However, the complications did not differ significantly between the two techniques.

Key Takeaways for Patients

  • Both tendon grafting and turnover split-lengthening technique can provide comparable functional outcomes and patient-reported satisfaction.
  • The choice of technique depends on individual factors, such as the availability of a healthy palmaris longus tendon and the presence of excessive scarring.
  • Patient selection and post-operative care are crucial for optimal outcomes.
  • Patients should discuss the potential benefits and risks of each technique with their surgeon to make informed decisions about their treatment.

Patient questions to ask their surgeon include:

  • What are the potential benefits and risks of each technique?
  • Which technique is best suited for my individual needs?
  • What are the expected outcomes and recovery time for the procedure?
  • What are the potential complications and how can they be managed?

Frequently Asked Questions

What is flexor tendon reconstruction?
Flexor tendon reconstruction is a surgical procedure used to repair damaged flexor tendons in the hand. The procedure involves using either a tendon graft or the turnover split-lengthening technique to reconstruct the damaged tendon.
What are the benefits of flexor tendon reconstruction?
The benefits of flexor tendon reconstruction include improved finger motion, grip strength, and overall hand function. The procedure can also reduce pain and improve the appearance of the hand.
What are the risks and complications of flexor tendon reconstruction?
The risks and complications of flexor tendon reconstruction include tendon adhesions, joint contractures, and bowstringing. Other potential complications include infection, nerve damage, and reactions to anesthesia.
How long does the recovery process take?
The recovery process for flexor tendon reconstruction typically takes 3-6 months. During this time, patients will need to undergo physical therapy to regain finger motion and strength.
What is the success rate of flexor tendon reconstruction?
The success rate of flexor tendon reconstruction is generally high, with 70-80% of patients achieving good or excellent outcomes. However, the success rate can vary depending on individual factors, such as the severity of the injury and the presence of underlying medical conditions.
More on: flexor tendon reconstruction Last reviewed: August 4, 2026

Community Disclaimer

This article reflects personal experiences and insights shared by members of the limb lengthening community. It is intended for informational and discussion purposes only, and does not constitute medical advice, diagnosis, or treatment. Individual experiences may vary. Always consult with a qualified orthopedic surgeon before making any medical decisions regarding limb lengthening procedures.

Explore Related Research

Clinical Insight

Brown Algae Ingredients in Skincare: Safety Guide for Patients

Overview Recent research by the Expert Panel for Cosmetic Ingredient Safety examined the safety of brown algae‑derived substances used in everyday cosmetics. Among the 82 brown‑algae ingredients listed in the International Cosmetic Ingredient Dictionary, the panel determined that 68 are safe at current concentrations, while data were insufficient for the remaining ones. This analysis matters because many moisturizers, sunscreens, and anti‑aging products contain these marine‑derived compounds, and patients often wonder whether they can trust the labels on their favorite skin‑care items. Understanding the scientific assessment helps consumers make informed choices, especially those with sensitive skin, allergies, or concerns about heavy‑metal contaminants such as arsenic. The findings also guide manufacturers in applying good manufacturing practices to limit possible impurities. What This Study Examined The panel reviewed the toxicology, exposure levels, and impurity profiles of brown algae‑derived ingredients that function primarily as skin‑conditioning agents. The assessment considered published peer‑reviewed data, industry reports, and regulatory submissions to decide whether each ingredient is safe for cosmetic use under typical conditions. Why This Matters for Patients Cosmetic products are applied directly to the skin, often daily and for years, so any hidden risks could accumulate over time. Knowing that 68 ingredients have been deemed safe reassures users, while the uncertainty surrounding the remaining 14 highlights the importance of reading labels, checking for third‑party testing, and discussing concerns with dermatologists. Medical Background Brown algae, also known as Phaeophyceae, are a rich source of polysaccharides, polyphenols, and lipids that are attractive for skin‑care formulations. These compounds can act as moisturizers, antioxidants, and anti‑inflammatory agents. However, during harvesting and processing, trace amounts of environmental contaminants—most notably arsenic—may be introduced. Because cosmetics are regulated differently from pharmaceuticals, the safety threshold for each ingredient depends on both its intrinsic toxicity and the concentration at which it is used in a product. The panel’s safety conclusions rely on the principle that if an ingredient’s exposure remains below the established no‑observed‑adverse‑effect level (NOAEL), it is unlikely to cause harm. How the Procedure Works In the context of cosmetics, “procedure” refers to the manufacturing steps that transform raw brown algae into usable ingredients. First, the algae are harvested, washed, and dried. Extraction methods—such as hot‑water extraction for polysaccharides (e.g., alginates) or solvent extraction for lipids (e.g., fucoxanthin)—are then applied. The extracts are purified, filtered, and finally blended into final product formulations at concentrations ranging from 0.1 % to 5 % depending on the intended function. Who Is a Candidate? Anyone who uses skin‑care products containing brown algae‑derived ingredients can be considered a “candidate.” Particular groups that may be more attentive include: Individuals with a history of contact dermatitis or allergic skin reactions. People living in regions with high environmental arsenic exposure who wish to avoid additional sources. Consumers seeking natural or marine‑based ingredients for their perceived gentleness. Clinical Summary Procedure: Use of brown algae‑derived ingredients in cosmetic products (e.g., moisturizers, sunscreens, anti‑aging creams). Typical Duration: Continuous daily application for months to years, depending on product use. Recovery: Not applicable – these are non‑invasive topical agents. Success Rate (general): 68 of 82 evaluated ingredients were deemed safe, indicating a high overall safety profile. Study Methodology The Expert Panel performed a systematic safety review following the Cosmetic Ingredient Review (CIR) framework. The process involved collecting all publicly available toxicological data, including animal studies, human repeat‑dose trials, and in‑vitro genotoxicity assays. The panel also examined impurity reports, particularly arsenic levels, from manufacturing batches submitted by industry. Patient Selection Criteria Because the assessment focused on ingredient safety rather than patient outcomes, the panel did not enroll human participants. Instead, the “population” consisted of all available scientific studies that met pre‑specified quality criteria (e.g., peer‑reviewed, controlled, and reproducible). Outcome Measures The primary outcomes were: Identification of a NOAEL for each ingredient. Assessment of potential adverse effects such as skin irritation, sensitization, or systemic toxicity. Quantification of arsenic and other heavy‑metal impurities relative to the International Council for Harmonisation (ICH) limits. Results & Findings The panel’s review yielded the following core findings: Key Outcomes Out of 82 brown algae‑derived ingredients, 68 were judged safe for use in cosmetics at the concentrations typically employed. Commonly safe ingredients include alginic acid, fucoidan, laminarin, and various brown‑algae extracts marketed for moisturizing or antioxidant effects. For the 14 ingredients lacking sufficient data, the panel could not reach a definitive safety conclusion; manufacturers are advised to generate additional toxicology data before market entry. Arsenic was identified as the most concerning impurity. Most tested batches contained arsenic levels well below the 0.5 ppm threshold considered acceptable for cosmetics, but the panel emphasized continued vigilance. Complications & Risks While the majority of ingredients are safe, the review highlighted potential risks: Skin irritation: Some polysaccharide preparations can cause transient erythema or a mild burning sensation, especially when applied to compromised skin. Allergic sensitization: Rare cases of contact allergy to algae‑derived proteins have been reported, warranting patch‑test confirmation in susceptible individuals. Heavy‑metal exposure: In the unlikely event of elevated arsenic in a batch, prolonged use could contribute to systemic toxicity, though current manufacturing controls keep levels well under regulatory limits. Data gaps: For the 14 ingredients with insufficient data, undiscovered adverse effects cannot be ruled out, underscoring the importance of manufacturer transparency. Key Takeaways for Patients Most brown algae‑derived ingredients (68/82) are considered safe when used as instructed on product labels. Check product labels for specific ingredient names such as “alginic acid,” “fucoidan,” or “laminarin” if you prefer marine‑based actives. If you have a history of skin allergies, perform a patch test before applying a new product containing algae extracts. Ask your dermatologist whether a product has been third‑party tested for arsenic and other heavy‑metal contaminants. Be cautious with products that do not disclose the exact concentration of algae‑derived ingredients or lack a clear manufacturing source. When in doubt, request the Safety Data Sheet (SDS) from the brand to verify that the ingredient falls within the panel’s safe‑use recommendations. Frequently Asked Questions Are brown algae extracts safe for everyday use? Yes. The Expert Panel found that 68 out of 82 evaluated algae‑derived ingredients are safe at the concentrations normally used in cosmetics (Source: PubMed / Europe PMC). Can brown algae ingredients cause allergic reactions? Allergic contact dermatitis is rare but possible. If you have a history of skin allergies, perform a patch test or consult a dermatologist before regular use. What is the risk of arsenic in my moisturizer? Arsenic can be present as an impurity, but current manufacturing practices keep levels well below the 0.5 ppm limit deemed acceptable for cosmetics. Reputable brands usually test for and disclose this. How can I identify products that contain brown algae ingredients? Look for ingredient names such as alginic acid, fucoidan, laminarin, brown algae extract, or specific scientific names like Fucus vesiculosus extract on the product’s ingredient list. Should I avoid products with brown algae if I’m pregnant? There is no evidence that the approved ingredients pose a risk during pregnancy. However, if you prefer to limit exposure, choose products that explicitly state they are pregnancy‑tested or consult your obstetrician. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Dedifferentiated Chondrosarcoma of Distal Femur – Diagnosis and Double‑Barrel Fibular Graft Reconstruction Guide

Overview Dedifferentiated chondrosarcoma (DCS) of the distal femur is an uncommon, aggressive bone cancer that often presents with pain, swelling, and rapid growth. A recent case report described a 48‑year‑old woman whose tumor required a limb‑salvage operation using a double‑barrel autologous fibular graft (Source: PubMed / Europe PMC). This guide translates that experience into clear, patient‑focused information, highlighting why accurate diagnosis, timely surgery, and modern reconstruction techniques matter for anyone facing this disease. The lessons from this case are relevant not only to patients diagnosed with DCS but also to anyone who experiences unexplained knee pain, swelling, or radiologic findings suggestive of an aggressive bone lesion. Understanding the diagnostic challenges, surgical options, and realistic expectations after reconstruction can empower patients to make informed decisions and collaborate effectively with their orthopedic oncology team. What This Study Examined The report examined a single patient with a distal‑femoral DCS. It detailed the imaging work‑up, the difficulty of obtaining a definitive diagnosis from core needle biopsy, rapid tumor progression on serial scans, and the eventual decision to perform wide excision followed by limb‑salvage reconstruction using a double‑barrel fibular graft. Why This Matters for Patients Because DCS combines a low‑grade cartilage tumor with a high‑grade sarcomatous component, missing the aggressive part on biopsy can delay life‑saving treatment. Moreover, the reconstruction technique described—double‑barrel fibular graft—offers an alternative to endoprosthetic replacement, preserving native bone and potentially reducing long‑term complications. Medical Background Dedifferentiated chondrosarcoma is a biphasic malignancy that contains both a well‑differentiated cartilage‑producing tumor and a suddenly appearing high‑grade spindle‑cell sarcoma. It most often arises in the femur, pelvis, or humerus and carries a poorer prognosis than conventional chondrosarcoma. The term DCS reflects the abrupt transition from a low‑grade to a high‑grade component, which can be missed on small tissue samples. When the tumor involves the distal femur—the lower part of the thigh bone near the knee—patients typically notice progressive pain, swelling, and reduced range of motion. Radiographs may show a lytic (bone‑destroying) lesion, while advanced imaging such as MRI or CT can reveal a heterogeneous mass with a sizable soft‑tissue component. How the Procedure Works The double‑barrel fibular graft technique involves harvesting two segments of the patient’s own fibula (the smaller bone of the lower leg). These segments are placed side‑by‑side (hence “double‑barrel”) to fill the bone defect left after tumor removal. The graft is secured with screws or a plate, and the surrounding soft tissue is reconstructed to protect the joint. Because the graft is autologous (autologous), it integrates with the host bone, promoting new bone formation and potentially allowing the patient to retain a more natural limb length. Who Is a Candidate? Ideal candidates are patients with a high‑grade bone sarcoma confined to a single bone segment, sufficient healthy surrounding soft tissue, and adequate vascular supply to support graft healing. Age, overall health, and personal goals (e.g., desire to avoid a large prosthetic implant) also influence candidacy. In the reported case, the patient was a relatively young, otherwise healthy adult with localized disease, making her a good candidate for this limb‑salvage approach. Clinical Summary Procedure: Wide excision of distal‑femoral DCS followed by reconstruction with a double‑barrel autologous fibular graft. Typical Duration: 3–5 hours of operative time, depending on tumor size and reconstruction complexity. Recovery: Hospital stay of 5–7 days; weight‑bearing is usually limited for 8–12 weeks while the graft consolidates. Success Rate (general): Limb‑salvage surgery for distal femur sarcoma achieves local control rates of 70‑85% and long‑term functional scores comparable to endoprosthetic replacement, though specific data for double‑barrel fibular grafts are limited to case series. Study Methodology Because the source is a single‑case report, the study design is descriptive rather than comparative. The patient was followed from initial presentation through 6 months post‑operative imaging to assess for recurrence. Patient Selection Criteria The report focused on one adult (48 years) who presented with progressive distal‑femoral pain and an imaging‑defined aggressive lesion. Core needle biopsy was inconclusive, prompting repeat imaging and eventual wide excision. No other patients were included. Outcome Measures The primary outcomes were histopathologic confirmation of DCS, radiographic evidence of graft incorporation, and absence of local recurrence at 6 months. Secondary outcomes included intra‑operative blood loss, length of hospital stay, and early postoperative complications. Results & Findings Histology revealed the classic biphasic pattern of DCS: a low‑grade chondroid area transitioning abruptly to a high‑grade spindle‑cell sarcoma. Wide surgical margins were achieved, and the double‑barrel fibular graft was secured without intra‑operative fracture of the remaining femur. Key Outcomes All surgical margins were negative (R0 resection), indicating complete tumor removal. At 6 months, plain radiographs and MRI showed satisfactory graft integration with callus formation and no radiographic signs of recurrence. The patient regained functional use of the leg, ambulating with a cane by month four and without assistive devices by month six. Complications & Risks The case report did not describe major complications, but the authors noted typical risks associated with limb‑salvage surgery and autologous fibular harvest, including: Donor‑site morbidity such as ankle instability or sensory changes. Non‑union or delayed union of the fibular graft. Infection of the surgical site. Hardware irritation or failure. Local recurrence of DCS, which remains a lifelong concern given the tumor’s aggressive nature. Key Takeaways for Patients Dedifferentiated chondrosarcoma is a high‑grade cancer; accurate diagnosis often requires multiple biopsies and careful imaging review. Early, wide surgical excision offers the best chance of local control. Double‑barrel fibular graft reconstruction can preserve the patient’s own bone, avoid a large prosthetic, and provide good functional results when performed by an experienced orthopedic oncologist. Recovery involves limited weight‑bearing for several months; physical therapy is essential to regain strength and gait. Patients should ask their surgeon about: What specific margins will be achieved and how they are confirmed? What are the alternatives (endoprosthesis vs. autograft) and their long‑term pros/cons? How will donor‑site pain be managed and what activities should be avoided after fibular harvest? What surveillance schedule is recommended to detect recurrence early? Frequently Asked Questions What is dedifferentiated chondrosarcoma and how does it differ from regular chondrosarcoma? Dedifferentiated chondrosarcoma (DCS) is a two‑component tumor that starts as a low‑grade cartilage cancer but suddenly develops a high‑grade sarcoma, making it much more aggressive than conventional chondrosarcoma. How can doctors be sure they have diagnosed DCS accurately? Diagnosis relies on a combination of imaging (MRI, CT) that shows heterogeneous features and a tissue biopsy that demonstrates the abrupt transition between cartilage and high‑grade spindle‑cell areas. Sometimes more than one biopsy is needed. Why might a surgeon choose a double‑barrel fibular graft instead of a knee prosthesis? The graft uses the patient’s own bone, avoids a large metal implant, and can provide better long‑term durability with fewer risks of prosthetic wear or loosening, especially for younger, active patients. What is the expected recovery timeline after this type of limb‑salvage surgery? Most patients stay in the hospital for a week, begin gentle range‑of‑motion exercises within a few days, and stay non‑weight‑bearing for 8–12 weeks. Full return to normal activities usually occurs by 4–6 months, depending on graft healing. Will the tumor ever come back after surgery? Because DCS is aggressive, there is a lifelong risk of recurrence. Ongoing surveillance with periodic MRI or CT scans, as recommended by the oncology team, is essential for early detection. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Femoroacetabular Impingement Syndrome

Overview Femoroacetabular impingement syndrome (FAIS) is a common cause of hip pain in young, active adults. The condition occurs when the ball and socket of the hip joint do not fit together perfectly, causing friction and potentially leading to avascular necrosis or osteoarthritis. A recent study published on professional female football players found that the prevalence of FAIS is low, while the prevalence of primary cam morphology is relatively high (Source: PubMed). The study examined the relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology in professional female football players. The findings of this study are significant, as they suggest that the aetiology of FAIS and primary cam morphology in female football players may not be solely driven by high load activity during skeletal maturation, but is likely multifactorial and may differ from that in males. What This Study Examined This study aimed to determine the prevalence of FAIS, primary cam morphology, pincer morphology, and acetabular dysplasia in professional female football players. The study also explored the dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. Why This Matters for Patients Understanding the prevalence and aetiology of FAIS and related hip morphologies is essential for patients, as it can help them make informed decisions about their treatment options. For example, patients with FAIS may benefit from hip preservation surgery, while patients with primary cam morphology may benefit from cam resection. Medical Background FAIS is a condition where the ball and socket of the hip joint do not fit together properly, causing friction and potentially leading to avascular necrosis or osteoarthritis. The condition can be caused by a variety of factors, including primary cam morphology, pincer morphology, and acetabular dysplasia. The diagnosis of FAIS typically involves a combination of physical examination, imaging studies, and patient history. The physical examination may include tests such as the flexion-adduction-internal rotation test and the internal hip rotation test. Imaging studies, such as radiographs and magnetic resonance imaging (MRI), may also be used to confirm the diagnosis. How the Procedure Works The treatment of FAIS typically involves a combination of conservative management and surgical intervention. Conservative management may include physical therapy and pain management. Surgical intervention may include hip preservation surgery and cam resection. Who Is a Candidate? Candidates for FAIS treatment typically include patients who have been diagnosed with the condition and have not responded to conservative management. Patients who are considering surgical intervention should be in good overall health and have a realistic understanding of the potential benefits and risks of the procedure. Clinical Summary Procedure: Hip preservation surgery, cam resection, and other surgical interventions Typical Duration: 1-2 hours Recovery: 2-6 months Success Rate (general): 80-90% Study Methodology This study was a cross-sectional study that included 100 professional female football players. The study used a combination of questionnaires, physical examination, and imaging studies to determine the prevalence of FAIS and related hip morphologies. The study also explored the dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. Patient Selection Criteria Patient selection criteria for this study included professional female football players who were between the ages of 18 and 30. Patients who had a history of hip surgery or had been diagnosed with hip osteoarthritis were excluded from the study. Outcome Measures Outcome measures for this study included the prevalence of FAIS and related hip morphologies, as well as the dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. Results & Findings The study found that the prevalence of FAIS was 3%, while the prevalence of primary cam morphology was 49%. The study also found that there was no dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. Key Outcomes Key outcomes of this study include the prevalence of FAIS and related hip morphologies, as well as the dose-response relationship between sport frequency, age of menarche, and the development of FAIS and primary cam morphology. These findings are significant, as they suggest that the aetiology of FAIS and primary cam morphology in female football players may not be solely driven by high load activity during skeletal maturation, but is likely multifactorial and may differ from that in males. Complications & Risks Complications and risks associated with FAIS treatment include avascular necrosis, osteoarthritis, and hip dislocation. Patients who are considering surgical intervention should be aware of these potential complications and risks and should discuss them with their doctor. Key Takeaways for Patients Key takeaways for patients include: FAIS is a common cause of hip pain in young, active adults. The prevalence of FAIS is low, while the prevalence of primary cam morphology is relatively high. The aetiology of FAIS and primary cam morphology in female football players may not be solely driven by high load activity during skeletal maturation, but is likely multifactorial and may differ from that in males. Patient should ask their surgeon about the potential benefits and risks of FAIS treatment, including hip preservation surgery and cam resection. Frequently Asked Questions What is FAIS? FAIS is a condition where the ball and socket of the hip joint do not fit together properly, causing friction and potentially leading to avascular necrosis or osteoarthritis. What are the symptoms of FAIS? Symptoms of FAIS may include hip pain, stiffness, and limited range of motion. How is FAIS diagnosed? Diagnosis of FAIS typically involves a combination of physical examination, imaging studies, and patient history. What are the treatment options for FAIS? Treatment options for FAIS may include conservative management and surgical intervention. What are the potential complications and risks of FAIS treatment? Potential complications and risks of FAIS treatment include avascular necrosis, osteoarthritis, and hip dislocation. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Thumb Fusion Surgery

Overview Thumb MCP fusion surgery is a procedure that involves joining the bones in the thumb joint to alleviate pain and improve function. This surgery is often performed to treat conditions such as OA, RA, and trauma. A recent study published on the use of Ni-Ti compression staples for MCP fusions of the thumb has shown promising results, with a high fusion rate and low reoperation rate (Source: PubMed). This study is significant because it provides valuable insights into the effectiveness of Ni-Ti staples in MCP fusion surgery. The findings of this study can help inform treatment decisions for patients with thumb joint conditions. MCP fusion surgery is typically considered for patients who have not responded to conservative treatments, such as physical therapy and medication. What This Study Examined The study examined the reoperation rate and fusion rate in patients who underwent MCP fusion surgery using Ni-Ti compression staples. The study included a total of 599 patients, with a mean age of 64.4 years, who underwent MCP fusion surgery between March 2008 and June 2024. Why This Matters for Patients The results of this study are important for patients because they provide information about the potential outcomes of MCP fusion surgery using Ni-Ti staples. Patients who are considering this surgery should be aware of the potential benefits and risks, including the risk of reoperation and complications. Medical Background MCP fusion surgery is a procedure that involves joining the bones in the thumb joint to alleviate pain and improve function. The surgery is typically performed to treat conditions such as OA, RA, and trauma. The goal of the surgery is to eliminate pain and improve function by stabilizing the joint. How the Procedure Works The procedure involves making an incision in the thumb and removing any damaged or arthritic tissue. The bones are then joined together using Ni-Ti compression staples, which provide compression across the joint to promote healing. The staples are made of a unique material that can withstand the stresses and strains of the thumb joint. Who Is a Candidate? Candidates for MCP fusion surgery typically include patients who have not responded to conservative treatments, such as physical therapy and medication. Patients who have severe OA or RA may be candidates for this surgery. Additionally, patients who have suffered a traumatic injury to the thumb joint may also be candidates for this surgery. Clinical Summary Procedure: MCP fusion surgery using Ni-Ti compression staples Typical Duration: 1-2 hours Recovery: 6-12 weeks Success Rate (general): 90-100% Study Methodology The study was a retrospective cohort study that included 599 patients who underwent MCP fusion surgery between March 2008 and June 2024. The patients were followed for a mean of 9.6 months, with a range of 4-12 weeks for clinical follow-up and 31.3 months for reoperation. Patient Selection Criteria The patients included in the study were those who underwent MCP fusion surgery using Ni-Ti compression staples. The patients were selected based on their medical records and operative reports. Outcome Measures The outcome measures included the reoperation rate and fusion rate. The reoperation rate was defined as the number of patients who required additional surgery after the initial procedure. The fusion rate was defined as the number of patients who achieved successful fusion of the bones in the thumb joint. Results & Findings The study found that the reoperation rate was 2.3%, with 9 patients requiring additional surgery for painful or prominent hardware and 7 patients requiring surgery for tendon adhesions. The fusion rate was 100%, with all patients achieving successful fusion of the bones in the thumb joint. Key Outcomes The key outcomes of the study included the high fusion rate and low reoperation rate. The study demonstrated that MCP fusion surgery using Ni-Ti compression staples is a effective procedure for treating thumb joint conditions. Complications & Risks The study identified several complications and risks associated with MCP fusion surgery, including painful or prominent hardware, tendon adhesions, and infection. Patients should be aware of these potential complications and discuss them with their surgeon before undergoing the procedure. Key Takeaways for Patients Patients who are considering MCP fusion surgery should be aware of the following key takeaways: MCP fusion surgery using Ni-Ti compression staples is a effective procedure for treating thumb joint conditions. The fusion rate is high, with 100% of patients achieving successful fusion of the bones in the thumb joint. The reoperation rate is low, with 2.3% of patients requiring additional surgery. Patients should be aware of the potential complications and risks associated with the procedure, including painful or prominent hardware, tendon adhesions, and infection. Patients should discuss their individual treatment options with their surgeon to determine the best course of treatment. Packages should ask their surgeon about the following: The potential benefits and risks of MCP fusion surgery The expected outcome of the procedure The potential complications and risks associated with the procedure The recovery time and rehabilitation process Frequently Asked Questions What is MCP fusion surgery? MCP fusion surgery is a procedure that involves joining the bones in the thumb joint to alleviate pain and improve function. The surgery is typically performed to treat conditions such as OA, RA, and trauma. What is the goal of MCP fusion surgery? The goal of MCP fusion surgery is to eliminate pain and improve function by stabilizing the joint. What are the potential benefits of MCP fusion surgery? The potential benefits of MCP fusion surgery include pain relief, improved function, and increased stability of the thumb joint. What are the potential complications and risks associated with MCP fusion surgery? The potential complications and risks associated with MCP fusion surgery include painful or prominent hardware, tendon adhesions, infection, and nerve damage. How long does the recovery process take after MCP fusion surgery? The recovery process typically takes 6-12 weeks, with most patients experiencing significant improvement in pain and function within 3-6 months after surgery. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →